ASPRE trial: performance of screening for preterm pre-eclampsia (Record no. 76322)

MARC details
000 -LEADER
fixed length control field 03185cam a2200157 4500
001 - CONTROL NUMBER
control field NMDX7419
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120401t2017 xxu||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Janga, D.
240 ## - UNIFORM TITLE
Uniform title <a href="Ultrasound in Obstetrics & Gynecology">Ultrasound in Obstetrics & Gynecology</a>
245 ## - TITLE STATEMENT
Title ASPRE trial: performance of screening for preterm pre-eclampsia
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Date of publication, distribution, etc. 2017
500 ## - GENERAL NOTE
General note NMUH Staff Publications
520 ## - SUMMARY, ETC.
Summary, etc. &lt;h4&gt;&lt;span style="font-size: 10pt;"&gt;OBJECTIVE: &lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: normal;"&gt;To examine the performance of screening for preterm and term pre-eclampsia (PE) in the study population participating in the ASPRE (Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence-Based Preeclampsia Prevention) trial.&lt;/span&gt;&lt;/span&gt;&lt;/h4&gt;&lt;h4&gt;&lt;span style="font-size: 10pt;"&gt;METHODS: &lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: normal;"&gt;This was a prospective first-trimester multicenter study on screening for preterm PE in 26 941 singleton pregnancies by means of an algorithm that combines maternal factors, mean arterial pressure, uterine artery pulsatility index and maternal serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation. Eligible women with an estimated risk for preterm PE of &amp;gt; 1 in 100 were invited to participate in a double-blind trial of aspirin (150 mg per day) vs placebo from 11-14 weeks until 36 weeks' gestation. In the aspirin group, the incidence of preterm PE was reduced by 62%. In the screened population, the detection rates (DR) and false-positive rates (FPR) for delivery with PE &amp;lt; 37 and ≥ 37 weeks were estimated after adjustment for the effect of aspirin in those receiving this treatment. We excluded 1144 (4.2%) pregnancies because of loss to follow-up or study withdrawal (n = 716), miscarriage (n = 243) or termination (n = 185).&lt;/span&gt;&lt;/span&gt;&lt;/h4&gt;&lt;h4&gt;&lt;span style="font-size: 10pt;"&gt;RESULTS: &lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: normal;"&gt;The study population of 25 797 pregnancies included 180 (0.7%) cases of preterm PE, 450 (1.7%) of term PE and 25 167 (97.6%) without PE. In combined first-trimester screening for preterm PE with a risk cut-off of 1 in 100, the DR was 76.7% (138/180) for preterm PE and 43.1% (194/450) for term PE, at screen-positive rate of 10.5% (2707/25 797) and FPR of 9.2% (2375/25 797).&lt;/span&gt;&lt;/span&gt;&lt;/h4&gt;&lt;h4&gt;&lt;span style="font-size: 10pt;"&gt;CONCLUSION: &lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: normal;"&gt;The performance of screening in the ASPRE study was comparable with that of a study of approximately 60 000 singleton pregnancies used for development of the algorithm; in that study, combined screening detected 76.6% of cases of preterm PE and 38.3% of term PE at a FPR of 10%.&lt;/span&gt;&lt;/span&gt;&lt;/h4&gt;
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://www.ncbi.nlm.nih.gov/pubmed/28741785">https://www.ncbi.nlm.nih.gov/pubmed/28741785</a>
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/doi/10.1002/uog.18816/epdf">http://onlinelibrary.wiley.com/doi/10.1002/uog.18816/epdf</a>
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Staff publications for NMDX Ferriman information and Library Service (North Middlesex) Ferriman information and Library Service (North Middlesex) Shelves 07/06/2022   07/06/2022 07/06/2022 Book
London Health Libraries Koha Consortium privacy notice